---
title: "Ivacaftor - Cystic fibrosis of the lung"
sidebar: mydoc_sidebar
permalink: db08820-mesh-d003550-1.html
toc: false 
---


Path ID: `DB08820_MESH_D003550_1`
{% include image.html url="images/db08820-mesh-d003550-1.png" file="db08820-mesh-d003550-1.png" alt="db08820-mesh-d003550-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C545203 | Ivacaftor | Drug |
| UniProt:P13569 | Cystic fibrosis transmembrane conductance regulator | Protein |
| MESH:D003550 | Cystic fibrosis of the lung | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Ivacaftor | INCREASES ACTIVITY OF | Cystic Fibrosis Transmembrane Conductance Regulator |
| Cystic Fibrosis Transmembrane Conductance Regulator | DISRUPTED BY | Cystic Fibrosis Of The Lung |
|---------|-----------|---------|

Comment: Ivacaftor as monotherapy has failed to show a benefit for patients with delta-F508 mutations

Reference: [https://go.drugbank.com/drugs/DB08820#mechanism-of-action](https://go.drugbank.com/drugs/DB08820#mechanism-of-action){:target="_blank"}